Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of isoquinoline compound, its intermediate, preparation method and application

A technology of isoquinoline and compounds, applied in the field of isoquinoline compounds, can solve the problems of needing improvement of specificity and weak signal of developer, etc., and achieve the effect of good binding ability

Active Publication Date: 2021-07-16
SHANGHAI RUXU BIOTECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem to be solved by the present invention is to solve the problems that the existing radioactively labeled tau protein imaging contrast agents have weak signals, the displayed dynamic range and the specificity for the target point need to be improved, thus providing a method that is compatible with the existing Isoquinoline compounds with completely different technologies, their intermediates, preparation methods and applications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of isoquinoline compound, its intermediate, preparation method and application
  • A kind of isoquinoline compound, its intermediate, preparation method and application
  • A kind of isoquinoline compound, its intermediate, preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0136] The preparation of embodiment 1 compound II-B---II-D

[0137]

[0138] General synthesis procedure: 1.0 mmol substrate 6, 5N CsF or NaNH under anhydrous and anaerobic conditions 2 , 5.0 mL DMF, and the reaction mixture was heated to 140-150° C. and stirred until the reaction was completed (the reaction time was 12 h, and the reaction was monitored by TLC or HPLC). The reaction mixture was separated between ethyl acetate and saturated brine (the amount of ethyl acetate and saturated brine used were both 200 mL), the organic phase was dried over magnesium sulfate, and the solvent was drained. The crude product was separated on a silica gel column using ethyl acetate and methanol (95:5, v / v) as mobile phase.

[0139] Compound II-B, yield 65%, purity>95%, 1 H NMR (400MHz; CDCl 3 ),δ9.19(s,1H,Ar-H),8.01(s,1H,Ar-H),7.88(d, 3 J HH =8.9Hz,1H,Ar-H),7.57(d, 3 J HH =8.9Hz,1H,Ar-H),7.24(m,1H,Ar-H).

[0140] Compound II-C, yield 47%, purity > 85%, 1 H NMR (400MHz; CDCl ...

Embodiment 2

[0142] The preparation of embodiment 2 compound II-C---II-D series

[0143]

[0144] Compound II-C synthesis steps: 1.0mmol substrate, 10N NaOCH 3 , 5.0 mL CH 3 OH, the reaction mixture was reacted at 80°C for 22 hours, and then washed with 20N H 2 SO 4 Neutralize the acidification and stir until the reaction is complete. The reaction mixture was partitioned between ethyl acetate and saturated brine. The organic solvent phase was dried in magnesium sulfate, and the solvent was drained, and the crude product was separated on a silica gel column, using ethyl acetate and methanol (95:5, v / v) as the mobile phase.

[0145] Compound II-D synthesis steps: 1.0 mmol substrate, 10N H 2 o 2 , 5.0 mL CHCl 3 , and the reaction mixture was stirred at 70 °C until the reaction was complete. The reaction mixture was partitioned between ethyl acetate and saturated brine. The organic solvent phase was dried in magnesium sulfate, and the solvent was drained, and the crude product was ...

Embodiment 3

[0146] The preparation of embodiment 3 compound II-E---II-G

[0147]

[0148] General synthesis procedure: 1.0 mmol substrate VI-A, 2.0 N (CF 3 CO) 2 O, 4.0N DABCO, 5.0mL CH 2 Cl 2 , and the reaction mixture was stirred at room temperature until the reaction was complete. Add excess K 2 CO 3 Solid, stirred for 1 ~ 2h, then filtered. The reaction mixture was added dropwise to 10 times the volume of diethyl ether, and the mixture was allowed to stand overnight. The solution was partially decanted and the solid was washed with diethyl ether. The solid was dissolved in 5.0 mL THF and 2.0N Bu 4 NF solution, the reaction mixture was stirred at 60 °C until the reaction was complete. The solvent was drained, and the crude product was separated with a silica gel column, using ethyl acetate and hexane (80:20, v / v) as the mobile phase.

[0149] Compound II-E, yield 78%, purity>95%, 1 H NMR (400MHz; CDCl 3 ),δ8.28-8.30(m,2H,Ar-H),7.88(d, 3 J HH =8.9Hz,1H,Ar-H),7.24(d, 3 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an isoquinoline compound, its intermediate, preparation method and application. The structure of the isoquinoline compounds of the present invention is shown in formula I, wherein R 1 and R 2 each independently selected from H, F, 18 F, NH 2 and NO 2 one of; R 3 , R 4 and R 5 each independently selected from H, NH 2 , NO 2 , CN, OH, C 1 ~C 4 Alkyl, C 1 ~C 4 alkoxy and C 1 ~C 4 One of the alkyl-amino groups; X is selected from CH 2 , one of NH, O and S; Y is CH or N; Z is CH or N. The isoquinoline compounds of the present invention have good binding ability to hyperphosphorylated tau protein; 18 After radiolabeling, F can be used as tau protein imaging contrast agent in positron emission tomography (PET), so as to be used for early diagnosis of Alzheimer's disease and tracking of drug efficacy.

Description

technical field [0001] The present invention relates to an isoquinoline compound, its intermediate, preparation method and application. Background technique [0002] Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive development. Generalized dementia is characterized by behavioral changes. This progressive, irreversible disorder of brain function affects the lives of millions of people and creates a devastating health burden worldwide. Over the past two decades, significant progress has been made in deciphering the pathogenesis and developing new treatments. The pathological features of AD include neural plaques of β-amyloid and neurofibrillary tangles of hyperphosphorylated tau protein. The recent direction of drug development for the treatment of AD is to control β-amyloid production, aggregation, deposition in the brain, accelerate the metabolism of amyloid from the brain, and prevent the aggregation of hyperphosphorylated tau ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/04C07D471/04C07D405/04C07D491/048C07D409/04C07D495/04C07D413/04C07D498/04C07D513/04C07D417/04C07D487/08A61K31/4725A61K51/04A61P25/28A61P25/00A61K101/02
CPCA61K51/0419A61K51/0431A61K51/0446A61K51/0453A61K51/0455C07D401/04C07D405/04C07D409/04C07D413/04C07D417/04C07D471/04C07D487/08C07D491/048C07D495/04C07D498/04C07D513/04A61K31/4725A61K51/04
Inventor 蔡勇全
Owner SHANGHAI RUXU BIOTECH